Taganahan, Ramel-wine B.
HRN: 11-03-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2023
CEFTRIAXONE 1G (VIAL)
06/17/2023
06/24/2023
IVT
1.1gram
Q12
Typhoid
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes